Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies

Decibel Cannabis

Market Cap: CA$72.1m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Planet 13 Holdings

Market Cap: CA$97.6m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

MariMed

Market Cap: CA$55.1m

Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.

Jushi Holdings

Market Cap: CA$137.8m

A vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States.

Thermo Fisher Scientific

Market Cap: CA$177.4b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Verano Holdings

Market Cap: CA$586.1m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Merck

Market Cap: CA$199.7b

Operates as a healthcare company worldwide.

Cresco Labs

Market Cap: CA$689.9m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Pfizer

Market Cap: CA$137.2b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Novo Nordisk

Market Cap: CA$1.7t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Johnson & Johnson

Market Cap: CA$425.3b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Delivra Health Brands

Market Cap: CA$5.9m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

Sanofi

Market Cap: CA$96.7b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

High Tide

Market Cap: CA$435.6m

Engages in the cannabis retail business in Canada.

Curaleaf Holdings

Market Cap: CA$2.8b

Produces and distributes cannabis products in the United States and internationally.

Cybin

Market Cap: CA$161.8m

A clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

Aurora Cannabis

Market Cap: CA$391.8m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Medicure

Market Cap: CA$11.5m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Crescita Therapeutics

Market Cap: CA$9.0m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

Devonian Health Group

Market Cap: CA$24.6m

Engages in the development of botanical drugs.

BioSyent

Market Cap: CA$130.6m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Novartis

Market Cap: CA$189.4b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

1933 Industries

Market Cap: CA$5.0m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

4Front Ventures

Market Cap: CA$4.6m

Engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States.

TILT Holdings

Market Cap: CA$2.0m

Provides various cannabis products and services in the United States, Canada, and internationally.

1CM

Market Cap: CA$45.9m

Operates as a multi-jurisdictional cannabis company in Canada.

Trulieve Cannabis

Market Cap: CA$1.9b

Operates as a cannabis retailer.

Fennec Pharmaceuticals

Market Cap: CA$236.3m

Operates as a commercial stage biopharmaceutical company in the United States.

NanoSphere Health Sciences

Market Cap: CA$359.6k

A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.

BriaCell Therapeutics

Market Cap: CA$22.9m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Auxly Cannabis Group

Market Cap: CA$195.5m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Theratechnologies

Market Cap: CA$210.6m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

Bausch Health Companies

Market Cap: CA$2.5b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

CordovaCann

Market Cap: CA$5.5m

Engages in identifying, funding, developing, and managing operations in the cannabis value chain business.

Telescope Innovations

Market Cap: CA$24.6m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

AbbVie

Market Cap: CA$393.3b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.